MedPath

Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain

The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

Not Applicable
Recruiting
Conditions
Pain
Arthroplasty Complications
Arthritis Knee
Interventions
First Posted Date
2023-11-01
Last Posted Date
2024-05-02
Lead Sponsor
Damascus University
Target Recruit Count
80
Registration Number
NCT06112548
Locations
🇸🇾

Damascus university, Damascus, Syrian Arab Republic

Evaluation of the Efficacy of Regional Anaesthesia for Analgesia After Laparoscopic Cholecystectomy

Not Applicable
Completed
Conditions
Postoperative Pain
Regional Anesthesia
Laparoscopic Cholecystectomy
Interventions
Procedure: M-TAPA block
Procedure: EXORA block
First Posted Date
2023-08-23
Last Posted Date
2024-08-12
Lead Sponsor
Bursa Yüksek İhtisas Education and Research Hospital
Target Recruit Count
90
Registration Number
NCT06008002
Locations
🇹🇷

Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey

Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain

Phase 2
Completed
Conditions
Acute Pain
Postoperative Pain
Interventions
Drug: etoricoxib-tramadol
First Posted Date
2023-08-16
Last Posted Date
2024-10-10
Lead Sponsor
Laboratorios Liomont
Target Recruit Count
58
Registration Number
NCT05995912
Locations
🇲🇽

Oaxaca Site Management Organization, Oaxaca, Mexico

Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries

Recruiting
Conditions
Post Operative Pain
Interventions
First Posted Date
2023-08-14
Last Posted Date
2024-02-28
Lead Sponsor
Zagazig University
Target Recruit Count
132
Registration Number
NCT05990686
Locations
🇪🇬

Zagazig University , Fuculty of Medicine, Zagazig, Sharquia, Egypt

Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain

Phase 2
Completed
Conditions
Post Operative Pain
Symptomatic Irreversible Pulpitis
Interventions
First Posted Date
2023-08-08
Last Posted Date
2024-08-07
Lead Sponsor
Dow University of Health Sciences
Target Recruit Count
47
Registration Number
NCT05982392
Locations
🇵🇰

Dow International Dental College, Karachi, Sindh, Pakistan

USG-Guided Infiltration Popliteal Artery Capsule Knee Block Versus Adductor Canal Block Application as Postoperative Analgesia

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
Drug: Morfin
First Posted Date
2023-07-21
Last Posted Date
2023-07-21
Lead Sponsor
Siirt Training and Research Hospital
Target Recruit Count
20
Registration Number
NCT05956275
Locations
🇹🇷

Bolu Abant İzzet Baysal University, Bolu, Turkey

Pain Management in Pediatric Adenotonsillectomy

Phase 3
Not yet recruiting
Conditions
Pain Management
Interventions
First Posted Date
2023-07-03
Last Posted Date
2023-07-11
Lead Sponsor
Al-Azhar University
Target Recruit Count
80
Registration Number
NCT05928520

Adjuvant Dexmedetomidine and Tramadol in Subcostal Transversus Abdominis Plan Block

Not Applicable
Completed
Conditions
Transversus Abdominis Plane Block
Interventions
Procedure: Dexmedetomidin + bupivacaine
First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Yuzuncu Yıl University
Target Recruit Count
60
Registration Number
NCT05905757
Locations
🇹🇷

Van Yuzuncu Yil University, Van, Turkey

"NSAIDs vs. Opiates: Which is More Effective in Managing Pain in Mild to Moderate Acute Pancreatitis?

Early Phase 1
Recruiting
Conditions
Acute Pancreatitis
Interventions
First Posted Date
2023-03-06
Last Posted Date
2023-04-06
Lead Sponsor
Hayatabad Medical Complex
Target Recruit Count
130
Registration Number
NCT05756504
Locations
🇵🇰

Hayatabad Medical Complex, Peshawar, Kpk, Pakistan

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

First Posted Date
2023-02-08
Last Posted Date
2024-12-16
Lead Sponsor
Unither Pharmaceuticals, France
Target Recruit Count
24
Registration Number
NCT05716763
Locations
🇯🇴

IPRC reserach site facility, Amman, Jordan

© Copyright 2025. All Rights Reserved by MedPath